The pros and cons of new prognostic eutos score for chronic myeloid leukemia patients.
Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy. Electronic address: breccia@bce.uniroma1.it.
Massimo
M
Breccia
Giuliana
G
Alimena
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D019937:Diagnostic Techniques and Procedures; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality*; D011379:Prognosis; D015996:Survival Rate
D000970:Antineoplastic Agents